- Pfizer profit misses; 2010 outlook below Street (Reuters)
- Now It’s Actavis vs Teva in Fight for Ratiopharm – Report (PharmaTimes)
- Roche FY Net Profit Down 22 Percent on Genentech Costs (PharmaLive)
- FDA Requests $4.03 Billion to Promote and Protect Public Health (World Pharma News)
- Glaxo in Up to $330 Mln Deal with Austrian Biotech (Reuters)
- Medicis Receives Approval for RESTYLANE(R) and PERLANE(R) With Lidocaine (CNN Money)
- Recordati’s Enlarged Prostate Drug Approved in Europe (PharmaTimes)
- GlaxoSmithKline And Austria’s Apeiron Sign Lung Drug Deal (The Wall Street Journal)
- Miner, Bank Gains See FTSE Ahead for Fourth Day (Reuters)
SUBSCRIBE